Summary:
A randomized, placebo-controlled clinical trial to assess the cardiovascular safety of Androgel in men over the age of 45 years old with low testosterone and a history of cardiovascular disease, such as a heart attack, stroke, coronary artery stents, cardiac bypass or peripheral vascular disease
Qualified Participants Must:
• Be men greater than or equal to 45 years old with a history of low testosterone and a histroy of cardiovascular disease
Qualified Participants May Receive:
Free study medication or placebo, free medical visits and bloodwork, and compensation of up to $65 per clinic visit or $15 per telephone visit